{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:40:25Z","timestamp":1781163625461,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["MRG5980198"],"award-info":[{"award-number":["MRG5980198"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["TRF-RTA6080003"],"award-info":[{"award-number":["TRF-RTA6080003"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","award":["PHD\/023\/2556 PS&NC"],"award-info":[{"award-number":["PHD\/023\/2556 PS&NC"]}],"id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biopha.2017.12.021","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T18:22:47Z","timestamp":1512757367000},"page":"1663-1672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats"],"prefix":"10.1016","volume":"97","author":[{"given":"Piangkwan","family":"Sa-nguanmoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongpan","family":"Tanajak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasiwan","family":"Kerdphoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thidarat","family":"Jaiwongkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasana","family":"Pratchayasakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipon","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn C.","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2017.12.021_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/en.2011-1502","article-title":"PPARgamma agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets","volume":"153","author":"Pipatpiboon","year":"2012","journal-title":"Endocrinology"},{"issue":"13\u201314","key":"10.1016\/j.biopha.2017.12.021_bib0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.lfs.2011.02.003","article-title":"Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone","volume":"88","author":"Pratchayasakul","year":"2011","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2017.12.021_bib0015","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biopha.2017.12.021_bib0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI67353","article-title":"Interplay between FGF21 and insulin action in the liver regulates metabolism","volume":"124","author":"Emanuelli","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.biopha.2017.12.021_bib0025","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1210\/en.2013-1191","article-title":"Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice","volume":"154","author":"Camporez","year":"2013","journal-title":"Endocrinology"},{"issue":"26","key":"10.1016\/j.biopha.2017.12.021_bib0030","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.biopha.2017.12.021_bib0035","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2017.12.021_bib0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/apha.12698","article-title":"Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats","volume":"217","author":"Tanajak","year":"2016","journal-title":"Acta Physiol. (Oxf.)"},{"issue":"5","key":"10.1016\/j.biopha.2017.12.021_bib0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1152\/ajpendo.00348.2009","article-title":"Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects","volume":"297","author":"Xu","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.biopha.2017.12.021_bib0050","doi-asserted-by":"crossref","first-page":"e0159191","DOI":"10.1371\/journal.pone.0159191","article-title":"Ampelopsin improves insulin resistance by activating PPARgamma and subsequently up-regulating FGF21-AMPK signaling pathway","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.12.021_bib0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yhbeh.2016.08.006","article-title":"FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats","volume":"85","author":"Sa-Nguanmoo","year":"2016","journal-title":"Horm. Behav."},{"key":"10.1016\/j.biopha.2017.12.021_bib0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pbb.2015.03.020","article-title":"Fibroblast growth factor 21 protects mouse brain against d-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation","volume":"133","author":"Yu","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.biopha.2017.12.021_bib0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2017.12.021_bib0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/joe.1.06904","volume":"191","author":"Parker","year":"2006","journal-title":"J. Endocrinol."},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2017.12.021_bib0075","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.2337\/dc11-s228","article-title":"Glycemic control impact on body weight potential to reduce cardiovascular risk: glucagon-like peptide 1 agonists","volume":"34","author":"Sesti","year":"2011","journal-title":"Diab. Care"},{"issue":"1","key":"10.1016\/j.biopha.2017.12.021_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-12-0521","article-title":"DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats","volume":"218","author":"Pintana","year":"2013","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2017.12.021_bib0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ejn.12088","article-title":"DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption","volume":"37","author":"Pipatpiboon","year":"2013","journal-title":"Eur. J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2017.12.021_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2017.12.021_bib0095","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","article-title":"The fasting polypeptide FGF21 can enter brain from blood","volume":"28","author":"Hsuchou","year":"2007","journal-title":"Peptides"},{"issue":"12","key":"10.1016\/j.biopha.2017.12.021_bib0100","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.2337\/db14-0541","article-title":"FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting","volume":"63","author":"Liang","year":"2014","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.biopha.2017.12.021_bib0105","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.biopha.2017.12.021_bib0110","doi-asserted-by":"crossref","first-page":"e82275","DOI":"10.1371\/journal.pone.0082275","article-title":"Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.12.021_bib0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-6750-10-14","article-title":"High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2017.12.021_bib0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2017.12.021_bib0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.biopha.2017.12.021_bib0130","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.transproceed.2009.09.076","article-title":"Effects of radiation on protein oxidation and lipid peroxidation in the brain tissue","volume":"41","author":"Gulbahar","year":"2009","journal-title":"Transplant. Proc."},{"issue":"11\u201312","key":"10.1016\/j.biopha.2017.12.021_bib0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.lfs.2012.08.017","article-title":"Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats","volume":"91","author":"Pintana","year":"2012","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2017.12.021_bib0140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1152\/jn.00365.2001","article-title":"Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices","volume":"87","author":"Chattipakorn","year":"2002","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.biopha.2017.12.021_bib0145","doi-asserted-by":"crossref","first-page":"e85115","DOI":"10.1371\/journal.pone.0085115","article-title":"Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity","volume":"9","author":"Sripetchwandee","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2017.12.021_bib0150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2017.12.021_bib0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.5414\/CPP48582","article-title":"Pharmacokinetics and pharmacodynamics of vildagliptin in Japanese patients with type 2 diabetes","volume":"48","author":"He","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2017.12.021_bib0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2015.07.003","article-title":"Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes","volume":"764","author":"Andersen","year":"2015","journal-title":"Eur J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2017.12.021_bib0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.diabet.2016.04.005","article-title":"Exenatide treatment decreases fasting fibroblast growth factor 21 levels in patients with newly diagnosed type 2 diabetes mellitus","volume":"42","author":"Hu","year":"2016","journal-title":"Diabetes Metab."},{"issue":"8","key":"10.1016\/j.biopha.2017.12.021_bib0170","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.metabol.2014.04.011","article-title":"Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis","volume":"63","author":"Lee","year":"2014","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.biopha.2017.12.021_bib0175","doi-asserted-by":"crossref","first-page":"e48392","DOI":"10.1371\/journal.pone.0048392","article-title":"Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.12.021_bib0180","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/751930","article-title":"Liraglutide suppresses obesity and hyperglycemia associated with increases in hepatic fibroblast growth factor 21 production in kkay mice","volume":"2014","author":"Nonogaki","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.biopha.2017.12.021_bib0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/JOE-16-0406","article-title":"Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats","volume":"232","author":"Tanajak","year":"2017","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2017.12.021_bib0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jdiacomp.2012.03.013","article-title":"Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates beta-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes","volume":"26","author":"Akarte","year":"2012","journal-title":"J. Diab. Compl."},{"issue":"2","key":"10.1016\/j.biopha.2017.12.021_bib0195","doi-asserted-by":"crossref","first-page":"e0148252","DOI":"10.1371\/journal.pone.0148252","article-title":"Fibroblast growth factor 21 (FGF21) protects against high fat diet induced inflammation and Islet hyperplasia in pancreas","volume":"11","author":"Singhal","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2017.12.021_bib0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/jnc.13563","article-title":"Mitochondrial dysfunction precedes depression of AMPK\/AKT signaling in insulin resistance induced by high glucose in primary cortical neurons","volume":"137","author":"Peng","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.biopha.2017.12.021_bib0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cell.2004.09.016","article-title":"PGC-1alpha: turbocharging mitochondria","volume":"119","author":"Houten","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2017.12.021_bib0210","first-page":"1","article-title":"Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1\u03b1 in human dopaminergic neurons via Sirtuin-1","volume":"3","author":"Tselykh","year":"2014","journal-title":"SpringerPlus"},{"issue":"6","key":"10.1016\/j.biopha.2017.12.021_bib0215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2017.12.021_bib0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biopha.2017.12.021_bib0225","doi-asserted-by":"crossref","first-page":"e0144064","DOI":"10.1371\/journal.pone.0144064","article-title":"Beneficial effects of evogliptin, a novel dipeptidyl peptidase 4 inhibitor, on adiposity with increased ppargc1a in white adipose tissue in obese mice","volume":"10","author":"Chae","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl (159)","key":"10.1016\/j.biopha.2017.12.021_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1742-1241.2007.01692.x","article-title":"Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes","author":"Rosenstock","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.biopha.2017.12.021_bib0235","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/dom.12436","article-title":"Clinical effectiveness and safety of vildagliptin in >19 000 patients with type 2 diabetes: the GUARD study","volume":"17","author":"Rosales","year":"2015","journal-title":"Diab. Obes. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2017.12.021_bib0240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diab. Care"},{"issue":"3","key":"10.1016\/j.biopha.2017.12.021_bib0245","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A model-based method for assessing insulin sensitivity from the oral glucose tolerance test","volume":"24","author":"Mari","year":"2001","journal-title":"Diab. Care"},{"key":"10.1016\/j.biopha.2017.12.021_bib0250","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2012.08.065","article-title":"Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity","volume":"239","author":"Suri","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2017.12.021_bib0255","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuroscience.2013.05.043","article-title":"Stress and excitatory synapses: from health to disease","volume":"248","author":"Timmermans","year":"2013","journal-title":"Neuroscience"},{"issue":"26","key":"10.1016\/j.biopha.2017.12.021_bib0260","doi-asserted-by":"crossref","first-page":"14731","DOI":"10.1073\/pnas.97.26.14731","article-title":"Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors","volume":"97","author":"Sarnyai","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biopha.2017.12.021_bib0265","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2017.12.021_bib0270","doi-asserted-by":"crossref","unstructured":"R.G. Morris, D.O. Hebb, The Organization of Behavior, Wiley New York; 1949, Brain research bulletin 50 (5\u20136) (1999) 437.","DOI":"10.1016\/S0361-9230(99)00182-3"},{"key":"10.1016\/j.biopha.2017.12.021_bib0275","doi-asserted-by":"crossref","DOI":"10.1038\/srep26866","article-title":"Vagus nerve stimulation exerts the neuroprotective effects in obese-insulin resistant rats, leading to the improvement of cognitive function","volume":"6","author":"Chunchai","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2017.12.021_bib0280","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yhbeh.2015.04.023","article-title":"Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions","volume":"72","author":"Pratchayasakul","year":"2015","journal-title":"Horm. Behav."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217349351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217349351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:32:06Z","timestamp":1780338726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217349351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":56,"alternative-id":["S0753332217349351"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.021","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}